SignaGen premade AAV-RAM-d2TTA-TRE-Cre-WPRE (Serotype 1) recombinant AAV vector, In Stock
AAV-RAM-d2TTA-TRE-Cre-WPRE (Serotype 1)

Price range: $368.00 through $668.00

In stock

Add to cart This product has multiple variants. The options may be chosen on the product page

AAV-RAM-d2TTA-TRE-Cre-WPRE (Serotype 1)

SKU: SL116567 Category:
  • Experimentally Validated
  • Reproducible Performance
  • Dedicated Scientific Support
  • Customization Options Available

Bulk Inquiry

Customize serotype, promoter, transgene, or reporter

Product Category: Pre-made recombinant AAV; Activity-dependent AAV; RAM-d2TTA/TRE AAV; Activity-dependent Cre AAV; AAV1-RAM-d2TTA-TRE-Cre-WPRE

Description:
AAV1-RAM-d2TTA-TRE-Cre-WPRE is a pre-packaged recombinant adeno-associated virus (rAAV) designed for neuronal activity-dependent expression of Cre recombinase. The vector utilizes the RAM (Robust Activity Marking) regulatory system, in which neuronal activity drives expression of the destabilized tetracycline-controlled transactivator d2TTA. In the absence of doxycycline, d2TTA activates the TRE (tetracycline response element) to drive Cre expression.

This activity-dependent transcriptional architecture enables genetic labeling or manipulation of neurons activated during a defined experimental period when combined with compatible Cre-dependent reporters, effectors, or floxed alleles. Cre-mediated recombination provides a lasting genetic mark that persists after activity-dependent Cre expression subsides, while WPRE supports transgene expression.

The vector is packaged in the AAV serotype 1 capsid. It is particularly useful for neuronal ensemble labeling, activity-dependent circuit studies, behavioral neuroscience, and investigations of learning, memory, and experience-dependent neural activation.

The RAM-d2TTA/TRE system operates through a Tet-Off mechanism: doxycycline suppresses TRE-driven Cre expression, while doxycycline withdrawal permits activity-dependent induction. This provides temporal control over the labeling window; restoring doxycycline suppresses further induction but does not reverse completed Cre-mediated recombination.

Size: 100 µL (2 x 50 µL, Std Pack)

Reconstitution Buffer: Sterile PBS supplemented with final 0.005% Pluronic F-68 and 200 mM NaCl

Infection Protocol:

Vector Map:
SignaGen AAV-RAM-d2TTA-TRE-Cre-WPRE (Serotype 1) premade recombinant AAV vector construct map showing RAM transgene, d2TTA transgene, TRE promoter, Cre recombinase, WPRE and AAV2 ITRs

CITATIONS

Shipping Weight 6 lbs
Unit Size

100 (2 x 50) µL at >10¹³ VG/mL, 50 µL at >10¹³ VG/mL

Custom Service Solutions


Looking for a customized solution? Our end-to-end capabilities support both in vitro and in vivo applications, with rigorous quality control, scalable production processes, and expert scientific oversight at every stage.

Important updates waiting for you!

Enter your email address below and subscribe to our newsletter

Enter your email to receive a coupon code for a 15% discount on catalog lentiviruses

This field is required

Unlock a special treat of savings waiting just for you! 🎁

Unlock exclusive deals awaiting you

Your exclusive code is ready! Copy it now!

Get 20% off now for all pre-made LVs